Urgent.News

What's breaking now, across thousands of outlets.

Continued

AI

AI-powered app maker Wabi pivots to a messaging experience

Wabi is repositioning its prompt-based app builder as a personal AI agent that can create interfaces on demand, combining chat, apps and ongoing tasks.

  • Wabi shifts focus to messaging experience with Wabi 2.0
  • AI-powered messenger integrates app generation for tasks
  • Founder Eugenia Kuyda emphasizes blending conversations and software

World

Morocco appoints first woman prime minister in its history

Dubai: Morocco’s King Mohammed VI on Tuesday appointed Fatima Ezzahra El Mansouri to lead the country’s government, making her the first woman to hold the post in the kingdom’s history.

  • King Mohammed VI appoints Fatima Ezzahra El Mansouri as Morocco's first female prime minister.
  • El Mansouri leads Authenticity and Modernity Party (PAM) with 97 seats in parliament.
  • She becomes second woman to head an Arab world government after Tunisia's Najla Bouden.

AI

ChatGPT's new plan costs $500 a month

OpenAI announced a $500 a month plan for ChatGPT. The company also downgraded the compute allowance of its $200 a month plan.

  • ChatGPT introduces $500 monthly Pro 500 plan
  • Plan offers Ultrafast computing with 8x speed boost
  • $200 Pro plan downgraded to 10x compute allowance

Tech

Parliament Information and Communications Committee Chairman calls for action over network disruptions in Northern Ghana

By Rachel Quartey The Chairman of Parliament’s Committee on Information and Communications, Dr. Abednego Lamangin Bandim, has called on MTN Ghana and the National Communications Authority (NCA) to take urgent action to address frequent telecommunications network disruptions in parts of northern Ghana.He said the recurring outages, coupled…

  • Dr. Bandim urges MTN Ghana and NCA to address network disruptions in northern Ghana.
  • Outages often last several hours, disrupting healthcare, education, and businesses.
  • Dr. Bandim calls for timely updates and improved communication protocols.

Health & Medicine

Research updates, September 29

A small clinical trial found Remdesivir was safe for people with Long COVID and that some exploratory results warrant a larger trial. The U.K. trial, which included 73 participants who took a five day course of the intravenous antiviral COVID-19 drug, was published in Oxford Open Immunology.

Continue reading →